11 results
The graph illustrates the differences in the onset and duration of action for various types of
and duration of action ... insulin: Rapid Acting ... Duration #Peaks #Timeline ... #Graph #Comparison ... #Pharmacology #
Insulin Comparison Chart - Peak and Duration

Inhaled, Rapid-acting (Analog), Regular, Intermediate-Acting (NPH), Detemir, Glargine, Degludec

- Stephen
Insulin Comparison ... Inhaled, Rapid-acting ... , Intermediate-Acting ... Peak #Duration #Pharmacology ... Endocrinology #Timing #Timeline
The principles of insulin adjustment guidance - Schematic diagram of insulin onset and time action profiles
onset and time action ... Duration #Peaks #Comparison ... #Pharmacology # ... Endocrinology #Timing #Timeline
Insulin and analogues onset of action, peak times and duration.

Follow at www.instagram.com/rxnotes for more!

#pharmacology #table #comparison
analogues onset of action ... #pharmacology #table ... #comparison #dosing ... duration #timing #timeline
Insulin Analogs - Short, Intermediate and Long Acting - Onset, Peak, Duration

#Diabetes #Insulin #Analogs #Onset #Duration
Intermediate and Long Acting ... Duration #Peaks #Comparison ... #Pharmacology # ... Endocrinology #Timing #Timeline
Renal Effect of NSAIDs Inhibition of Prostaglandin Synthesis

 - Renal disease, Cardiovascular disease -> Decreased renal
prostaglandin synthesis, leaving ... actions of Vasoconstrictors ... Prostaglandins #Pharmacology ... #Pathophysiology
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics Pharmacology ... , Intermediate Action ... Blockade, Fast Action ... Antiarrhythmics #Pharmacology ... Classification #Classes #pathophysiology
Drug-Induced Edema
Drug-induced edema is caused by many drugs & can coincide with or worsen pre-existing peripheral
blood vessels, leading ... Medication #Causes #Differential ... #Pharmacology # ... Pathophysiology
Iron Deficiency in Congestive Heart Failure (CHF)

Iron deficiency (ID) in heart failure is a common comorbidity
50% of patients, leading ... ] Treatment Options ... #Failure #CHF #pharmacology ... #pathophysiology
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
dissociation rate, leading ... pharmacological action ... margin of safety in pharmacology ... Pharmacokinetics #Comparison ... #Table #Pharmacology